Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.
Neural circuits respond to rapid dopamine surges
Researchers assess the pharmacodynamics of dopamine signaling, brain connectivity/activity, and self-documented ‘high’ following methylphenidate exposure.v